AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32

Authors: VANEMMERIK NEM VAESSEN LMB KNOOP CJ DAANE CR BALK AHMM MOCHTAR B CLAAS FHJ WEIMAR W
Citation: Nem. Vanemmerik et al., KINETICS OF CIRCULATING CYTOTOXIC T-LYMPHOCYTE PRECURSORS THAT HAVE AHIGH AVIDITY FOR DONOR ANTIGENS - CORRELATION WITH THE REJECTION STATUS OF THE HUMAN CARDIAC ALLOGRAFT, Transplant immunology, 6(3), 1998, pp. 153-160

Authors: KOELMAN CA MULDER A JUTTE NHPM VAESSEN LMB BALK AHMM WEIMAR W DOXIADIS IIN CLAAS FHJ
Citation: Ca. Koelman et al., THE APPLICATION OF HUMAN MONOCLONAL-ANTIBODIES FOR MONITORING DONOR DERIVED SOLUBLE HLA CLASS-I MOLECULES IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS, Human immunology, 59(2), 1998, pp. 106-114

Authors: VANEMMERIK NEM KNOOP CJ VAESSEN LMB BALK AHMM MOCHTAR B CLASS FHJ WEIMAR W
Citation: Nem. Vanemmerik et al., C1.7 MONOCLONAL-ANTIBODY DESIGNATES HIGH-AVIDITY CD4(-LYMPHOCYTES INVOLVED IN CLINICAL HEART REJECTION() CYTOTOXIC T), Transplantation, 66(1), 1998, pp. 135-138

Authors: VANBESOUW NM LOONEN EHM VAESSEN LMB BALK AHMM CLAAS FHJ WEIMAR W
Citation: Nm. Vanbesouw et al., THE FREQUENCY AND AVIDITY OF COMMITTED CYTOTOXIC T-LYMPHOCYTES (CCTL)FOR DONOR HLA CLASS-I AND CLASS-II ANTIGENS AND THEIR RELATION WITH GRAFT VASCULAR-DISEASE, Clinical and experimental immunology, 111(3), 1998, pp. 548-554

Authors: VANEMMERIK NEM LOONEN EHM VAESSEN LMB BALK AHMM MOCHTAR B CLAAS FHJ WEIMAR W
Citation: Nem. Vanemmerik et al., THE AVIDITY, NOT THE MERE PRESENCE, OF PRIMED CYTOTOXIC T-LYMPHOCYTESFOR DONOR HUMAN-LEUKOCYTE CLASS-II ANTIGENS DETERMINES THEIR CLINICALRELEVANCE AFTER HEART-TRANSPLANTATION, The Journal of heart and lung transplantation, 16(2), 1997, pp. 240-249

Authors: VANBESOUW NM DAANE CR VAESSEN LMB VANGELDER T MOCHTAR B BALK AHMM WEIMAR W
Citation: Nm. Vanbesouw et al., NONSPECIFIC IMMUNE REACTIVITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS RELATED TO GRAFT VASCULAR-DISEASE, Transplantation proceedings, 29(6), 1997, pp. 2544-2545

Authors: VANBESOUW NM DAANE CR VAESSEN LMB MOCHTAR B BALK AHMM WEIMAR W
Citation: Nm. Vanbesouw et al., DONOR-SPECIFIC CYTOKINE PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES INDUCES AND MAINTAINS GRAFT VASCULAR-DISEASE IN HUMAN CARDIAC ALLOGRAFTS, Transplantation, 63(9), 1997, pp. 1313-1318

Authors: VANEMMERIK NEM DAANE CR KNOOP CJ HESSE C VAESSEN LMB BALK AHMM MOCHTAR B CLAAS FHJ WEIMAR W
Citation: Nem. Vanemmerik et al., THE AVIDITY OF ALLOSPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) DETERMINES THEIR CYTOKINE PRODUCTION PROFILE, Clinical and experimental immunology, 110(3), 1997, pp. 447-453

Authors: VANBESOUW NM VAESSEN LMB BALK AHMM MOCHTAR B CLAAS FHJ WEIMAR W
Citation: Nm. Vanbesouw et al., CSA THERAPY AFFECTS THE DIRECT AND INDIRECT ANTIGEN-PRESENTATION PATHWAY IN CARDIAC ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(6), 1996, pp. 3135-3136

Authors: VANGELDER T ZIETSE R YZERMANS JNM RISCHENVOS J VAESSEN LMB WEIMAR W
Citation: T. Vangelder et al., LONG-TERM FOLLOW-UP AFTER INDUCTION TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN KIDNEY ALLOGRAFT RECIPIENTS -A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Transplantation proceedings, 28(6), 1996, pp. 3221-3222

Authors: VANEMMERIK NEM VAESSEN LMB BALK AHMM BOS E CLAAS FHJ WEIMAR W
Citation: Nem. Vanemmerik et al., PROGRESSIVE ACCUMULATION OF CTL WITH HIGH AVIDITY FOR DONOR ANTIGENS DURING THE DEVELOPMENT OF ACUTE CARDIAC REJECTION, Transplantation, 62(4), 1996, pp. 529-536

Authors: VANGELDER T BALK AHMM JONKMAN FAM ZIETSE R ZONDERVAN P HESSE CJ VAESSEN LMB MOCHTAR B WEIMAR W
Citation: T. Vangelder et al., A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION, Transplantation, 62(1), 1996, pp. 51-55

Authors: VANBESOUW NM VAESSEN LMB DAANE CR JUTTE NHPM BALK AHMM CLASS FHJ WEIMAR W
Citation: Nm. Vanbesouw et al., PERIPHERAL MONITORING OF DIRECT AND INDIRECT ALLOANTIGEN PRESENTATIONPATHWAYS IN CLINICAL HEART-TRANSPLANT RECIPIENTS, Transplantation, 61(1), 1996, pp. 165-167

Authors: PATIJN GA VAESSEN LMB WEIMAR W CLAAS FHJ JUTTE NHPM
Citation: Ga. Patijn et al., CULTURE OF GRAFT-INFILTRATING CELLS FROM CRYOPRESERVED ENDOMYOCARDIALBIOPSIES, Cryobiology, 33(4), 1996, pp. 465-471

Authors: VAESSEN LMB SCHIPPER F KNOOP C CLAAS FHJ WEIMAR W
Citation: Lmb. Vaessen et al., INVERTED V-DELTA-1 V-DELTA-2 RATIO WITHIN THE T-CELL RECEPTOR (TCR)-GAMMA-DELTA T-CELL POPULATION IN PERIPHERAL-BLOOD OF HEART-TRANSPLANT RECIPIENTS/, Clinical and experimental immunology, 103(1), 1996, pp. 119-124

Authors: VANBESOUW NM DAANE CR VAESSEN LMB BALK AHMM CLAAS FHJ ZONDERVAN PE JUTTE NHPM WEIMAR W
Citation: Nm. Vanbesouw et al., DIFFERENT PATTERNS IN DONOR-SPECIFIC PRODUCTION OF T-HELPER-1 AND T-HELPER-2 CYTOKINES BY CELLS INFILTRATING THE REJECTING CARDIAC ALLOGRAFT, The Journal of heart and lung transplantation, 14(5), 1995, pp. 816-823

Authors: VANGELDER T MULDER AH BALK AHMM MOCHTAR B HESSE CJ BAAN CC VAESSEN LMB WEIMAR W
Citation: T. Vangelder et al., INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS, The Journal of heart and lung transplantation, 14(2), 1995, pp. 346-350

Authors: LEEUWENBERG JFM FROON AHM VAESSEN LMB HOITSMA AJ ABRAMOWICZ D VANHOOFF JP BUURMAN WA
Citation: Jfm. Leeuwenberg et al., SOLUBLE TUMOR NECROSIS FACTOR-RECEPTORS ARE NOT A USEFUL MARKER OF ACUTE ALLOGRAFT-REJECTION - A STUDY IN PATIENTS WITH RENAL OR CARDIAC ALLOGRAFTS, Transplant international, 8(6), 1995, pp. 459-465

Authors: KLOOTWIJK W VAESSEN LMB BERNARD BF RONDEEL JMM DEGREEF WJ VISSER TJ
Citation: W. Klootwijk et al., PRODUCTION AND CHARACTERIZATION OF MONOCLONAL AND POLYCLONAL ANTIBODIES AGAINST THYROTROPIN-RELEASING-HORMONE, Hybridoma, 14(3), 1995, pp. 285-290

Authors: HESSE CJ VANGELDER T VAESSEN LMB KNOOP CJ BALK AHMM YZERMANS JNM JUTTE NHPM WEIMAR W
Citation: Cj. Hesse et al., PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION, Immunopharmacology, 30(3), 1995, pp. 237-246

Authors: VANGELDER T ZIETSE R YZERMANS JNM VAESSEN LMB MULDER AH WEIMAR W
Citation: T. Vangelder et al., MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) PREVENTS EARLY REJECTION AFTER KIDNEY-TRANSPLANTATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Kidney international, 47(2), 1995, pp. 708-708

Authors: BAAN CC VAESSEN LMB LOONEN EHM BALK AHMM JUTTE NHPM CLAAS FHJ WEIMAR W
Citation: Cc. Baan et al., THE EFFECT OF ANTITHYMOCYTE GLOBULIN THERAPY ON FREQUENCY AND AVIDITYOF ALLOSPECIFIC COMMITTED CTL IN CLINICAL HEART-TRANSPLANTS, Transplantation proceedings, 27(1), 1995, pp. 482-484

Authors: VAESSEN LMB BAAN CC DAANE CR LOONEN EHM BALK AHMM JUTTE NHPM MOCHTAR B CLAAS FHJ WEIMAR W
Citation: Lmb. Vaessen et al., IMMUNOLOGICAL MONITORING IN PERIPHERAL-BLOOD AFTER HEART-TRANSPLANTATION - FREQUENCIES OF T-HELPER CELLS AND PRECURSORS OF CYTOTOXIC T-CELLS WITH HIGH AVIDITY FOR DONOR ANTIGENS CORRELATE WITH REJECTION, Transplantation proceedings, 27(1), 1995, pp. 485-487

Authors: VANBESOUW NM DAANE CR BAAN CC MOL WM VAESSEN LMB NIESTERS HGM JUTTE NHPM WEIMAR W
Citation: Nm. Vanbesouw et al., CONCORDANCE OF MESSENGER-RNA EXPRESSION AND PROTEIN-PRODUCTION OF IL-2 AND IL-4 BY HUMAN HEART GRAFT-INFILTRATING LYMPHOCYTES, Transplantation proceedings, 27(1), 1995, pp. 488-488

Authors: VANGELDER T KNOOP CJ HESSE CJ VAESSEN LMB BALK AHMM YZERMANS JNM WEIMAR W
Citation: T. Vangelder et al., PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Transplantation proceedings, 27(1), 1995, pp. 856-858
Risultati: 1-25 | 26-32